🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Arcellx, Inc.

ACLX Healthcare
$114.77 +$0.02 (0.02%)
Market Cap: $6.73 B
Gurus Holding
4
Popularity Rank
#2365
% of Shares Held
0.66%
Net Activity (Q4 2025)
+$21.64 M

Guru Ownership Trend

Guru Analysis for Arcellx, Inc. (ACLX)

Arcellx, Inc. (ACLX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $44.38 M.

Top institutional holders include Ken Fisher and Paul Tudor Jones.

Institutional sentiment is currently Bullish. This is evidenced by a $21.64 M net inflow during the quarter.

Recent activity highlights Ken Fisher who opened a new position. Conversely, Cliff Asness reduced exposure by 74.9%.

Key Holders

Top 5 by Value

$21.05 M
$641,698
$518,992

Top 5 by Conviction

Recent Activity Breakdown (Q4 2025)

+$24.05 M
Total Buy Value
New Buys 2
Additions 0
-$2.41 M
Total Sell Value
Reductions 1
Sold Out 1

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
2
Net Buyers
2

FAQs for Arcellx, Inc. (ACLX)

Major holders include Ken Fisher ($21.05 M), Paul Tudor Jones ($3 M), Joel Greenblatt ($641,698). According to the latest reported data, 4 tracked investment managers collectively hold approximately 386,686 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $21.64 M, with 2 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited ACLX. The total reported sell value was $2.41 M.

Yes, 2 managers opened new positions in ACLX, and 0 increased their existing holdings. The total reported buy value was $24.05 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% New Buy 322,855 $21.05 M Q4 2025
0.01% New Buy 46,029 $3 M Q4 2025
0.00% 9,842 $641,698 Q4 2025
0.00% Reduce -74.9% 7,960 $518,992 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form